Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
John N. Spencer Jr.Director | GeoVax LabsGOVX | Open-market buy | 25/10/17 | 25/10/20 | 10,000 sh | $0.55 | $5,500 | +87.7% |
Kelly T. McKee Jr.Chief Medical Officer | GeoVax LabsGOVX | Open-market buy | 25/08/07 | 25/08/08 | 1,107 sh | $0.67 | $741.69 | +46.4% |
John N. Spencer Jr.Director | GeoVax LabsGOVX | Open-market buy | 25/04/10 | 25/04/11 | 10,000 sh | $0.98 | $9,800 | +713.3% |
John W. SharkeyVP, Business Development | GeoVax LabsGOVX | Open-market buy | 25/04/10 | 25/04/10 | 6,000 sh | $0.99 | $5,940 | +3141.4% |
David A. DoddPresident, CEO | GeoVax LabsGOVX | Open-market buy | 25/04/01 | 25/04/01 | 10,000 sh | $1.08 | $10,800 | +37.5% |
GeoVax LabsGOVX | Open-market buy | 25/03/31 | 25/03/31 | 6,800 sh | $1.08 | $7,344 | +94.3% | |
David A. DoddPresident, CEO | GeoVax LabsGOVX | Open-market buy | 24/08/09 | 24/08/12 | 8,000 sh | $1.95 | $15,600 | +42.9% |
GeoVax LabsGOVX | Open-market buy | 24/02/21–24/02/22 | 24/02/22 | 8,729 sh2 trades | $2.26avg. | $19,752.43 | +87.9% | |
GeoVax LabsGOVX | Open-market buy | 24/02/07 | 24/02/07 | 2,000 sh | $2.77 | $5,540 | +38.4% | |
Kelly T. McKee Jr.Chief Medical Officer | GeoVax LabsGOVX | Open-market buy | 23/12/22 | 23/12/26 | 6,944 sh | $0.36 | $2,499.84 | +24.1% |
Kelly T. McKee Jr.Chief Medical Officer | GeoVax LabsGOVX | Open-market buy | 23/09/25 | 23/09/27 | 9,653 sh | $0.52 | $5,019.56 | +50.3% |
David A. DoddPresident, CEO | GeoVax LabsGOVX | Open-market buy | 23/08/25 | 23/08/28 | 35,087 sh | $0.57 | $19,999.59 | +30.8% |
GeoVax LabsGOVX | Open-market buy | 23/08/18 | 23/08/21 | 10,000 sh | $0.52 | $5,200 | +14.7% | |
David A. DoddPresident, CEO | GeoVax LabsGOVX | Open-market buy | 23/04/24 | 23/04/25 | 32,000 sh | $0.64 | $20,480 | +39.1% |
GeoVax LabsGOVX | Open-market buy | 23/04/20 | 23/04/21 | 8,000 sh | $0.63 | $5,040 | +13.3% |